Your browser doesn't support javascript.
loading
A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas.
Shankaran, Veena; Xiao, Hong; Bertwistle, David; Zhang, Ying; You, Min; Abraham, Pranav; Chau, Ian.
Afiliação
  • Shankaran V; Division of Oncology, Department of Medicine, Seattle Cancer Care Alliance, Seattle, WA, USA. vshank@uw.edu.
  • Xiao H; Bristol Myers Squibb, Lawrenceville, NJ, USA.
  • Bertwistle D; Bristol Myers Squibb, Uxbridge, Middlesex, UK.
  • Zhang Y; Bristol Myers Squibb, Lawrenceville, NJ, USA.
  • You M; Bristol Myers Squibb, Lawrenceville, NJ, USA.
  • Abraham P; Bristol Myers Squibb, Lawrenceville, NJ, USA.
  • Chau I; Gastrointestinal and Lymphoma Unit, The Royal Marsden Hospital, Sutton, Surrey, UK.
Adv Ther ; 38(1): 707-720, 2021 01.
Article em En | MEDLINE | ID: mdl-33244736

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article